Citadel Advisors
KOD icon

Citadel Advisors’s Kodiak Sciences KOD Stock Holding History

Citadel Advisors’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88M Buy
99,700
+5,700
+6% +$222K ﹤0.01% 5172
2026
Q1 		$3.58M Buy
94,000
+86,200
+1,105% +$2.23M ﹤0.01% 4922
2025
Q4 		$218K Sell
7,800
-26,200
-77% -$537K ﹤0.01% 10856
2025
Q3 		$557K Buy
+34,000
New +$293K ﹤0.01% 8862
2025
Q2 		– Sell
-700
Closed -$1.96K – 13896
2025
Q1 		$1.96K Sell
700
-20,500
-97% -$111K ﹤0.01% 14079
2024
Q4 		$211K Buy
21,200
+15,400
+266% +$88.5K ﹤0.01% 10358
2024
Q3 		$15.1K Buy
5,800
+2,300
+66% +$6.11K ﹤0.01% 12983
2024
Q2 		$8.22K Sell
3,500
-3,800
-52% -$12.9K ﹤0.01% 13203
2024
Q1 		$38.4K Buy
7,300
+1,600
+28% +$7.84K ﹤0.01% 12438
2023
Q4 		$17.3K Sell
5,700
-4,000
-41% -$8.9K ﹤0.01% 12751
2023
Q3 		$17.5K Sell
9,700
-109,200
-92% -$385K ﹤0.01% 12727
2023
Q2 		$820K Buy
118,900
+115,000
+2,949% +$703K ﹤0.01% 6873
2023
Q1 		$24.2K Buy
3,900
+2,000
+105% +$14K ﹤0.01% 12917
2022
Q4 		$13.6K Sell
1,900
-17,700
-90% -$127K ﹤0.01% 13436
2022
Q3 		$152K Buy
19,600
+3,500
+22% +$34K ﹤0.01% 10682
2022
Q2 		$123K Sell
16,100
-104,100
-87% -$731K ﹤0.01% 11186
2022
Q1 		$928K Buy
120,200
+82,700
+221% +$3.23M ﹤0.01% 7878
2021
Q4 		$3.18M Buy
37,500
+5,000
+15% +$509K ﹤0.01% 5226
2021
Q3 		$3.12M Sell
32,500
-1,400
-4% -$129K ﹤0.01% 5267
2021
Q2 		$3.15M Sell
33,900
-8,700
-20% -$835K ﹤0.01% 5477
2021
Q1 		$4.83M Buy
42,600
+7,500
+21% +$1.02M ﹤0.01% 4330
2020
Q4 		$5.16M Buy
35,100
+11,500
+49% +$1.28M ﹤0.01% 3626
2020
Q3 		$1.4M Buy
23,600
+13,800
+141% +$693K ﹤0.01% 5403
2020
Q2 		$530K Sell
9,800
-1,400
-13% -$79K ﹤0.01% 6967
2020
Q1 		$534K Buy
11,200
+600
+6% +$36K ﹤0.01% 6364
2019
Q4 		$763K Buy
+10,600
New +$386K ﹤0.01% 6092

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Citadel Advisors's KOD Position: Q2 2026 in Review

Citadel Advisors reduced its Kodiak Sciences (KOD) stake by 82% in Q2 2026, selling an estimated $27.8M and leaving 157,524 shares worth $6.14M. The position accounts for ﹤0.01% of the portfolio, ranked #4377.

Citadel Advisors first reported a position in KOD in Q2 2019 and has held it in 23 quarters since. The position peaked at $33.2M in Q1 2026. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Citadel Advisors held 157,524 shares of Kodiak Sciences worth $6.14M as of Q2 2026.
  • Citadel Advisors sold 713,264 Kodiak Sciences shares in Q2 2026, an estimated $27.8M.
  • Kodiak Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4377 holding.
  • Citadel Advisors first reported a position in Kodiak Sciences in Q2 2019 and has held it in 23 quarters since.
  • Citadel Advisors's Kodiak Sciences position peaked at $33.2M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.